Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

Clinical trial NCT00597402 · COMPLETED

Trial details

NCT number: NCT00597402
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma Brain Tumor

Start date: 2007-07-01
Primary completion: 2011-08-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.